The aging brain and Alzheimer's disease: New ideas for targeting synaptic dysfunction

Optimal functioning of neural networks is critical to the complex cognitive processes of memory, language, emotion and reasoning that deteriorate in people suffering from Alzheimer's disease. On May 18, 2011, the New York Academy of Sciences and the Alzheimer's Drug Discovery Foundation will bring together expert researchers and physicians for "Targeting Synaptic Dysfunction in Alzheimer's Disease", a day-long conference aimed at fostering greater understanding of the mechanisms by which synaptic connections are formed, how they create neural networks, and how this information can be used in the development of new drugs to protect and maintain neuronal function and connectivity. This conference will provide an overview of the process of synaptic plasticity in normal aging and in neurodegenerative disease, and outline new targets for drug discovery.

WHAT:
Conference: Targeting Synaptic Dysfunction in Alzheimer's Disease

WHO:

Speakers:

Ottavio Arancio, MD, PhD

The Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University

Gilbert Di Paolo, PhD

Columbia University

Vahram Haroutunian, PhD

Mount Sinai School of Medicine

Barbara L. Hempstead, MD, PhD

Weill Medical College of Cornell University

Eric Klann, PhD

New York University

Mark P. Mattson, PhD

National Institute on Aging

Stephen M. Strittmatter, MD, PhD

Yale University School of Medicine

Grace E. Stutzmann, PhD

Rosalind Franklin University / The Chicago Medical School

Lawrence P. Wennogle, PhD

Intra-Cellular Therapeutics

WHEN:
Wednesday, May 18, 2011 | 9:00 AM - 4:00 PM

Networking reception to follow

WHERE:
The New York Academy of Sciences

7 World Trade Center, 250 Greenwich St., 40th floor, NYC

Provided by New York Academy of Sciences